Single-use technologies and facility layout – a paradigm shift
Posted on February 26, 2013
By: Alain Pralong, Vice President for New Product Introduction and Technical Life Cycle Management
GSK Biologicals
Abstract Biopharmaceutical industry based on recombinant DNA technology has started more than 30 years ago and continuously evolved. At the beginning, traditional chemical engineering based on glass and stainless steel was applied to support development and manufacturing of biopharmaceuticals. Incr...
To read the full article and other articles in this issue, please register for a free account or log in.
We will not sell or give your information to a third party. See our Privacy Policy
Related Topics and Keywords
biosimilar, capital expenditure (CAPEX), operation expenditures (OPEX), rocking plate bioreactors, Single-use technologies, vaccine
Related Product Videos
Capto™ Core 700 - GE Healthcare Life Sciences
FlexMoSys™ - Sartorius Stedim Biotech
Related Products
Capto™ Core 700 - GE Healthcare Life SciencesSartorius Stedim Biotech lauches Sartoguard NF prefilter series
Subscribe to our FREE newsletter and WEBINAR UPDATES
We will not sell or give your information to a third party. See our Privacy Policy
